Your Article Summary
Prognostic impact of tumour volume and lymph node involvement in intermediate stage T1b1 to T2b cancer of the uterine cervix
Bulletin du Cancer, 06/29/09
Goudy G et al. - Stage T2b and pelvic lymph node involvement, but not tumour volume, are the major prognostic factors in intermediate stage cervical cancers. Pelvic lymph node involvement should be determined before treatment
Related Articles
Transvaginal doppler sonography for assessment the response to radiotherapy in locally advanced squamous cervical cancer: a preliminary study
Archives of Medical Science, 11/03/09
Relevance Score: 81%
Advantages and Disadvantages of Current Prophylactic Vaccines Against HPV
Archives of Medical Research, 11/03/09
Relevance Score: 78%
Breast cancer with synchronous massive metastasis in the uterine cervix
Archives of Gynecology and Obstetrics, 11/02/09
Relevance Score: 78%
Menopausal status: A possible predictive factor for recurrence in women with cancer of the uterine cervix without pelvic lymph node metastasis
European Journal of Obstetrics & Gynecology and Reproductive Biology, 10/09/09
Relevance Score: 78%
Use of Fertility Drugs and Risk of Uterine Cancer: Results From a Large Danish Population-based Cohort Study
American Journal of Epidemiology, 11/04/09
Relevance Score: 70%
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Significance of Signet-ring cells seen in exfoliative and aspiration cytopathology
Diagnostic Cytopathology, 12/02/09
A rare case of pulmonary cryptococcal inflammatory myofibroblastic tumor diagnosed by fine needle aspiration cytology
Diagnostic Cytopathology, 12/02/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Human papillomavirus infection in women with and without cervical cancer in Nepal
Cancer Causes and Control, 12/02/09
Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation
Diagnostic Cytopathology, 12/02/09
Treatment of recurrent platinum-resistant ovarian cancer with pegylated liposomal doxorubicin ; An evaluation of the therapeutic index with special emphasis on cardiac toxicity
Chemotherapy, 12/01/09

See Latest Articles